Find and Pitch Jounalists, Get Your Story Covered

Tags: hodgkin lymphoma relapse radiotherapy chemotherapy classical hodgkin lymphoma

	Profile	Recent Articles on Subject
1	Wayne Kuznar MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Using Immune Biomarkers to Guide Treatment in TNBC - 23 days ago
2	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Frontline Mosunetuzumab Shows High Response Rates in Follicular Lymphoma - 27 days ago TIL Therapy May Offer Novel Approach for Metastatic Lung Cancer - 7 months ago Pirtobrutinib Shows Potential in Heavily Pretreated Follicular Lymphoma - about 1 year ago Novel Combination Active in Large B-Cell Lymphoma, Even After CAR-T - about 1 year ago Liso-Cel a Potential New CAR-T Option for High-Risk R/R Follicular Lymphoma - about 1 year ago Responses to Mosunetuzumab in Follicular Lymphoma Remain Durable at 3 Years - about 1 year ago Positive Results for Odronextamab in Relapsed/Refractory DLBCL - about 1 year ago
3	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	STAT+: For a leukemia that keeps returning, AbbVie drug may offer chance for a deep remission - about 1 month ago STAT+: A targeted therapy shows it can offer a ‘last, great chance’ for some acute leukemia patients - about 1 year ago STAT+: Was CAR-T therapy a bystander or driver of lymphoma? Researchers examine first published case - about 1 year ago STAT+: FDA investigating whether CAR-T, a treatment for cancer, can also cause lymphoma - about 1 year ago
4	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	SABCS 2024: Harnessing the Power of Tumor-Infiltrating Lymphocytes to Revolutionize Breast Cancer Treatment - about 1 month ago New Strategies in SCLC and DLBCL Are Transforming the Treatment Landscape - about 2 months ago ELA026 Receives Orphan Drug Designation to Treat Hemophagocytic Lymphohistiocytosis - 3 months ago FDA Approves PD-L1 IHC 22C3 to Identify Gastric or Gastroesophageal Junction Adenocarcinoma - about 1 year ago
5	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma - about 1 month ago Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers - 5 months ago Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 6 months ago PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma - 10 months ago Year in Review: Follicular Lymphoma - about 1 year ago Can ctDNA Guide Radiation Use in Oligometastatic NSCLC? - over 1 year ago
6	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Scottish medicines consortium approves CAR T-cell therapy for blood cancer - 2 months ago
7	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Brentuximab Vedotin Shows 37% Reduction in Risk of Death for DLBCL - 7 months ago Study: Mutation Found to Make Follicular Lymphoma More Susceptible to Experimental Drug - 10 months ago Study: Lymphoma Patients Recover Longer for Pneumonia - 10 months ago Neoadjuvant Chemotherapy Could Help Patients With Breast Cancer Skip Regional Nodal Irradiation - 12 months ago
8	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study - 7 months ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - about 1 year ago Lymphoma Drug Copanlisib to Be Pulled From U.S. Market - about 1 year ago
9	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Epstein-Barr and MS; When Lewy Pathology Starts; Alzheimer's Blood Test Assessed - 10 months ago
10	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Patients With CLL Present Heterogeneously - 11 months ago

Journalists covering hodgkin lymphoma